These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38878804)

  • 1. The main molecular mechanisms of ferroptosis and its role in chronic kidney disease.
    Wang F; Huang X; Wang S; Wu D; Zhang M; Wei W
    Cell Signal; 2024 Sep; 121():111256. PubMed ID: 38878804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanisms of ferroptosis in the pathogenesis of kidney diseases.
    Liu J; Chen J; Lv J; Gong Y; Song J
    J Nephrol; 2024 May; 37(4):865-879. PubMed ID: 38704472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium thiosulfate through preserving mitochondrial dynamics ameliorates oxidative stress induced renal apoptosis and ferroptosis in 5/6 nephrectomized rats with chronic kidney diseases.
    Cheng YH; Yao CA; Yang CC; Hsu SP; Chien CT
    PLoS One; 2023; 18(2):e0277652. PubMed ID: 36795670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDAC3 aberration-incurred GPX4 suppression drives renal ferroptosis and AKI-CKD progression.
    Zhang L; Chen F; Dong J; Wang R; Bi G; Xu D; Zhang Y; Deng Y; Lin W; Yang Z; Cao W
    Redox Biol; 2023 Dec; 68():102939. PubMed ID: 37890360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis and Necroptosis in the Kidney.
    Belavgeni A; Meyer C; Stumpf J; Hugo C; Linkermann A
    Cell Chem Biol; 2020 Apr; 27(4):448-462. PubMed ID: 32302582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of ferroptosis in the development of acute and chronic kidney diseases.
    Zhou Y; Zhang J; Guan Q; Tao X; Wang J; Li W
    J Cell Physiol; 2022 Dec; 237(12):4412-4427. PubMed ID: 36260516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferroptosis in renal fibrosis: a mini-review.
    Yang SQ; Zhao X; Zhang J; Liao DY; Wang YH; Wang YG
    J Drug Target; 2024 Aug; 32(7):785-793. PubMed ID: 38721679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formononetin ameliorates ferroptosis-associated fibrosis in renal tubular epithelial cells and in mice with chronic kidney disease by suppressing the Smad3/ATF3/SLC7A11 signaling.
    Zhu B; Ni Y; Gong Y; Kang X; Guo H; Liu X; Li J; Wang L
    Life Sci; 2023 Feb; 315():121331. PubMed ID: 36586573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-214-3p aggravates ferroptosis by targeting GPX4 in cisplatin-induced acute kidney injury.
    Zhou J; Xiao C; Zheng S; Wang Q; Zhu H; Zhang Y; Wang R
    Cell Stress Chaperones; 2022 Jul; 27(4):325-336. PubMed ID: 35366755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Road from AKI to CKD: Molecular Mechanisms and Therapeutic Targets of Ferroptosis.
    Guo R; Duan J; Pan S; Cheng F; Qiao Y; Feng Q; Liu D; Liu Z
    Cell Death Dis; 2023 Jul; 14(7):426. PubMed ID: 37443140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferroptosis and kidney disease.
    Martin-Sanchez D; Fontecha-Barriuso M; Martinez-Moreno JM; Ramos AM; Sanchez-Niño MD; Guerrero-Hue M; Moreno JA; Ortiz A; Sanz AB
    Nefrologia (Engl Ed); 2020; 40(4):384-394. PubMed ID: 32624210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ferroptosis in chronic kidney disease.
    Li S; Han Q; Liu C; Wang Y; Liu F; Pan S; Zuo L; Gao D; Chen K; Feng Q; Liu Z; Liu D
    Cell Commun Signal; 2024 Feb; 22(1):113. PubMed ID: 38347570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal Iron and Lipid Metabolism Mediated Ferroptosis in Kidney Diseases and Its Therapeutic Potential.
    Zhang X; Li X
    Metabolites; 2022 Jan; 12(1):. PubMed ID: 35050181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitexin attenuates chronic kidney disease by inhibiting renal tubular epithelial cell ferroptosis via NRF2 activation.
    Song J; Wang H; Sheng J; Zhang W; Lei J; Gan W; Cai F; Yang Y
    Mol Med; 2023 Oct; 29(1):147. PubMed ID: 37891461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediated tubular ferroptosis.
    Wang B; Yang LN; Yang LT; Liang Y; Guo F; Fu P; Ma L
    Acta Pharmacol Sin; 2024 Jan; 45(1):150-165. PubMed ID: 37696989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting ferroptosis in acute kidney injury.
    Ni L; Yuan C; Wu X
    Cell Death Dis; 2022 Feb; 13(2):182. PubMed ID: 35210424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy of OTUD5 destabilizes GPX4 to confer ferroptosis-dependent kidney injury.
    Chu LK; Cao X; Wan L; Diao Q; Zhu Y; Kan Y; Ye LL; Mao YM; Dong XQ; Xiong QW; Fu MC; Zhang T; Zhou HT; Cai SZ; Ma ZR; Hsu SW; Wu R; Chen CH; Yan XM; Liu J
    Nat Commun; 2023 Dec; 14(1):8393. PubMed ID: 38110369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Deep Insight into Ferroptosis in Renal Disease: Facts and Perspectives.
    Han Z; Luo Y; Chen H; Zhang G; You L; Zhang M; Lin Y; Yuan L; Zhou S
    Kidney Dis (Basel); 2024 Jun; 10(3):224-236. PubMed ID: 38835406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy-dependent ferroptosis in kidney disease.
    Yang Y; Cheng J; Lin Q; Ni Z
    Front Med (Lausanne); 2022; 9():1071864. PubMed ID: 36755884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HOXD10 attenuates renal fibrosis by inhibiting NOX4-induced ferroptosis.
    Li X; Ma TK; Wang P; Shi H; Hai S; Qin Y; Zou Y; Zhu WT; Li HM; Li YN; Yin L; Xu YY; Yang Q; Zhang S; Ding H
    Cell Death Dis; 2024 Jun; 15(6):398. PubMed ID: 38844470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.